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ABSTRACT
Aim: To evaluate the relationship between system
delay and 30-day and long-term mortality in patients
with anterior versus non-anterior ST-elevation
myocardial infarction (STEMI).
Methods: We conducted a prospective observational
cohort study. Patients with STEMI who were
transported to the Isala Hospital, Zwolle, and
underwent primary percutaneous coronary intervention
(pPCI) from 2005 until 2010 were included. These
patients were divided into quartiles of system delay
(time from first medical contact until reperfusion
therapy): Q1–Q4.
Results: In total, 3041 patients were included in our
study. 41% (n=1253) of the patients had an anterior
myocardial infarction (MI) and 59% of the patients
(n=1788) had a non-anterior MI. Only in patients with
an anterior MI, prolonged system delay was associated
with a higher mortality (30-day Q1: 2.6%, Q2: 3.1%,
Q3: 6.8%, Q4: 7.4%, p=0.001; long-term Q1: 12.8%,
Q2: 13.7%, Q3: 24.1%, Q4: 22.6%, p<0.001). After
multivariable adjustment, prolonged system delay was
associated with a higher 30-day and long-term mortality
in patients with an anterior MI (30 day Q2: HR 1.18,
95% CI (0.46 to 3.00), Q3: HR 2.45, 95% CI (1.07 to
5.63), Q4: HR 2.25, 95% CI (0.97 to 5.25)); long-term
Q2: HR 1.09, 95% CI (0.71 to 1.68), Q3: HR 1.68, 95%
CI (1.13 to 2.49), Q4: HR 1.55, 95% CI (1.03 to 2.33)),
but not in patients with a non-anterior MI.
Conclusions: Prolonged system delay significantly
increased short-term as well as long-term mortality in
patients with an anterior MI. This effect was not
demonstrated in patients with a non-anterior MI.
Therefore, it is of the greatest importance to minimise
system delay in patients who present with an anterior MI.
INTRODUCTION
As stated in the guidelines of the American
College of Cardiology/American Heart
Association (ACC/AHA) and of the European
Society of Cardiology (ESC), it is crucial to
perform rapid reperfusion therapy in patients
with ST-segment elevated myocardial infarc-
tion (STEMI),1 2 because every minute of
delay in these patients affects mortality.3
Therefore, currently time delays like system
delay, patient delay, transportation delay,
door-in-door-out time and door-to-balloon
(D2B) time care are of great concern for
patients with STEMI.4–8 System delay, deﬁned
as time from ﬁrst medical contact (FMC, ie,
EMS call) to reperfusion therapy, is a relatively
new time delay which can be optimised by
optimising the system. As demonstrated by
Terkelsen et al,4 system delay was independ-
ently associated with mortality. Since we
hypothesised that this effect would be the most
apparent in high-risk patients, we have investi-
gated the effect of system delay on 30-day and
KEY MESSAGES
What is already known about this subject?
It is known that system delay is independently asso-
ciated with mortality.
What does this study add?
We hypothesised that the effect of system delay on
mortality would be most apparent in high-risk
patients (patients with an anterior myocardial
infarction) compared with low-risk patients
(patients with a non-anterior myocardial infarction).
How might this impact on clinical practice?
Focusing on system delay, especially in high-risk
patients, may improve clinical practice since we
have demonstrated that prolonged system delay sig-
nificantly increased short-term as well as long-term
mortality in high-risk patients. This effect was not
demonstrated in low-risk patients.
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on long-term mortality in patients with an anterior myocar-
dial infarction (MI) versus a non-anterior MI.
METHODS AND ANALYSIS
Population
All patients with consecutive STEMI, who were trans-
ported to our percutaneous coronary intervention (PCI)
centre with the intention to perform primary PCI
(pPCI), from 2005 until 2010, were prospectively regis-
tered in a dedicated database. Criteria for the diagnosis
of STEMI were: (1) history of cardiac symptoms for at
least 30 min in the last 12 h or between 12 and 24 h if
they had persistent symptoms with evidence of ongoing
ischaemia; (2) elevated levels of creatine kinase or creat-
ine kinase-MB and (3) concurrent ECG changes:
ST-segment elevation of >0.1 mV in at least two adjacent
ECG leads.9
Infarct size was calculated as the peak level of creatine
kinase (peak CK) within 24 h after admission.10 The
municipal registration in the Netherlands was consulted
for the mortality of all patients in this study.
The included population was divided into four groups
according to the quartiles of system delay (Q1, Q2, Q3
and Q4). System delay was deﬁned as the time from
FMC, that is, EMS call to reperfusion therapy. Four
other time intervals were also evaluated: (1) symptom
onset (SO) diagnosis: time from SO to indication MI
(time diagnostic ECG) either in the ambulance or at a
spoke centre, (2) diagnosis door PCI: time from diagno-
sis to arrival at the PCI centre, (3) D2B: time from
arrival at the PCI centre to balloon inﬂation (BI), and
(4) total ischaemic time: time from SO to BI.
Patients were excluded if one of the following criteria
was met: patients were walk-ins, they were not treated by
PCI, D2B time was >180 min, system delay was unknown
or mortality could not be retrieved.
pPCI procedure
The staff of the catheterisation laboratory of the PCI
centre was preinformed about the estimated time of
arrival of the patient and was activated well before the
arrival of the patient. In case the staff lived more than
30 min away from the PCI centre, they had to stay in the
PCI centre while being on-call. All patients were treated
prehospital with an intravenous bolus of 5000 IU of
unfractionated heparin and 500 mg aspirin intraven-
ously. During the study period, the administration of clo-
pidogrel on top of aspirin and heparin as prehospital
treatment was implemented at 1 July 2006. The adminis-
tration of GPIIBIIIA blockers in the prehospital phase
was left to the discretion of the referring physicians.
The location of the acute vessel occlusion was deter-
mined in this study by the PCI operator. Consequently,
two groups were made according to the location: left
anterior descending artery (LAD; anterior MI) versus
non-LAD (non-anterior MI).
Statistical analysis
Statistical analysis was performed with SPSS V.20.0.
Continuous data were expressed as mean±SD or median
and IQR. Categorical data were presented as percen-
tages. A Kruskal-Wallis test was used for continuous data
since these were non-Gaussian distributed. A Pearson’s
χ2 test was used for categorical data. The continuous
variable infarct size was converted into a dichotomous
variable by dividing the de-continuous variable in IQRs
and deﬁning the IQR 0.75–1.00 as large enzymatic
infarct size (75th centile). A p for trend was calculated
for large enzymatic infarct size, and for 30-day and long-
term mortality between the quartiles of system delay.
To assess whether anterior MI might interfere with the
relationship between system delay and 30-day and long-
term mortality, interaction testing was performed.
Logistic regression analyses were performed to estimate
the effect of system delay on large enzymatic infarct size.
Variables included in the models were age, gender,
smoking, diabetes mellitus (DM), hypertension, hyper-
cholesterolaemia, previous MI, previous PCI, previous cor-
onary artery bypass grafting (CABG), type of triage, ST
deviation on diagnostic ECG and the quartiles of system
delay. Cox regression analysis was performed to estimate
the effect of system delay on 30-day and on long-term mor-
tality. Variables included in the models for 30-day mortality
were age, gender, DM, hypertension, type of triage,
thrombolysis in myocardial infarction (TIMI) risk score
and the quartiles of system delay. For the Cox regression
analysis of long-term mortality the previous MI, previous
PCI and previous CABG were added.
All the above described statistical tests were performed
two sided. In all the statistical analyses, p values <0.05
were considered as statistically signiﬁcant.
The study was conducted according to the principles of
the Declaration of Helsinki and the protocol was approved
by the local institutional review board. No extramural
funding was used to support this work. The authors are
fully responsible for the design and conduct of this study,
all study analyses and drafting and editing of the paper.
RESULTS
From 2005 until 2010, 4655 patients were referred to
our hospital with the intention to perform pPCI. In
total, 312 patients (7.7%) were walk-ins at the PCI
centre; 668 patients did not undergo PCI (14.3%); for
344 patients, the D2B time was >180 min (7.4%); for 245
patients, system delay was unknown (5.3%); and in the
case of 45 patients (1.0%), mortality could not be
retrieved. Of the remaining 3041 patients, 41%
(n=1253) of the patients had an anterior MI and 59%
(n=1788) had a non-anterior MI. There was a signiﬁcant
interaction effect between anterior infarction and the
quartiles of system delay on 30-day (p=0.048) and on
long-term mortality (p=0.027). Therefore, the results are
presented separately for patients with an anterior MI
and patients with a non-anterior MI.
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Anterior MI
The baseline characteristics are described in table 1.
Patients with a prolonged system delay were older, were
less often triaged in the ﬁeld and had less ST-deviation
on the diagnostic ECG. Gender, DM and the TIMI risk
score differed among the quartiles of system delay. The
time intervals are illustrated in ﬁgure 1A. All time delays
were signiﬁcantly different between the quartiles of
system delay. The median follow-up time was 5.3
(3.6–6.6) years. System delay was independently
associated with a large enzymatic infarct size (Q2: OR
1.85, 95% CI (1.19 to 2.86), Q3: OR 1.80, 95% CI (1.15
to 2.81), Q4: OR 1.15, 95% CI (0.72 to 1.84)). After Cox
regression analysis, prolonged system delay was inde-
pendently associated with 30-day mortality (Q2: HR 1.18,
95% CI (0.46 to 3.00), Q3: HR 2.45, 95% CI (1.07 to
5.63), Q4: HR 2.25, 95% CI (0.97 to 5.25)) and with
long-term mortality (Q2: HR 1.09, 95% CI (0.71 to
1.68), Q3: HR 1.68, 95% CI (1.13 to 2.49), Q4: HR 1.55,
95% CI (1.03 to 2.33)) (ﬁgure 2A).
Table 1 Baseline characteristics
System delay in quartiles
(min)
Q1: 72.0
(62.0–78.0)
Q2: 92.0
(87.0–97.0)
Q3: 114.0
(108.0–121.0)
Q4: 160.0
(142.0–190.0)
p
Value
Characteristic
Anterior MI (n=313) (n=321) (n=323) (n=296)
Age years (mean±SD) 62.6±12.5 (n=313) 62.2±12.7 (n=321) 65.8±12.6 (n=323) 64.5±13.2 (n=296) 0.001
Male gender 247/313 (78.9%) 241/321 (75.1%) 218/323 (67.5%) 218/296 (73.6%) 0.011
Previous MI 20/312 (6.4%) 27/321 (8.4%) 34/323 (10.5%) 32/296 (10.8%) 0.189
Previous CABG 3/313 (1.0%) 4/321 (1.2%) 6/323 (1.9%) 3/296 (1.0%) 0.734
Previous PCI 22/313 (7.0%) 24/321 (7.5%) 23/321 (7.2%) 32/296 (10.8%) 0.266
Hypertension 107/313 (34.2%) 88/320 (27.5%) 112/320 (35.0%) 108/295 (36.6%) 0.077
DM 25/313 (8.0%) 31/321 (9.7%) 50/323 (15.5%) 28/296 (9.5%) 0.012
Hypercholesterolemia 50/311 (16.1%) 53/319 (16.6%) 62/321 (19.3%) 67/294 (22.8%) 0.130
Smoking 124/312 (39.7%) 134/319 (42.0%) 111/317 (35.0%) 116/295 (39.3%) 0.332
Killip class >1 292/313 (93.3%) 299/321 (93.1%) 300/323 (92.9%) 265/294 (90.1%) 0.413
TIMI risk score
(mean±SD, median (IQR))
3.24±2.12
3.0 (1.0–4.0)
(n=311)
3.22±2.07
3.0 (1.0–5.0)
(n=321)
3.56±2.09
2.0 (3.0–5.0)
(n=323)
3.82±2.30
4.0 (2.0–5.0)
(n=294)
<0.001
Field triage 269/313 (85.9%) 239/321 (74.5%) 196/323 (60.7%) 134/296 (45.3%) <0.001
GPIIBIIIA blocker* 82/263 (31.2%) 92/275 (33.5%) 99/283 (35.0%) 99/249 (39.8%) 0.217
ST-segment deviation
(diagnostic ECG)
13.48±8.76
11.0 (8.0–17.0)
(n=201)
12.51±7.87
11.0 (7.0–16.0)
(n=216)
12.51±8.41
11.0 (7.0–16.0)
(n=227)
11.45±10.53
8.0 (5.0–15.0)
(n=220)
0.001
Multivessel disease 130/313 (41.5%) 142/320 (44.4%) 137/322 (42.5%) 119/295 (40.3%) 0.774
Non-anterior MI (n=462) (n=429) (n=448) (n=449)
Age years (mean±SD) 62.5±11.7 (n=462) 63.5±12.2 (n=429) 63.1±12.0 (n=448) 63.4±12.1 (n=449) 0.488
Male gender 338/462 (73.2%) 323/429 (75.3%) 318/448 (71.0%) 327/449 (72.8%) 0.556
Previous MI 42/459 (9.2%) 41/427 (9.6%) 37/445 (8.3%) 64/448 (14.3%) 0.015
Previous CABG 10/461 (2.2%) 14/428 (3.3%) 16/447 (3.6%) 28/449 (6.2%) 0.012
Previous PCI 44/461 (9.5%) 44/428 (10.3%) 41/447 (9.2%) 52/447 (11.6%) 0.628
Hypertension 153/460 (33.3%) 137/427 (32.1%) 169/445 (38.0%) 176/446 (39.5%) 0.061
DM 52/461 (11.3%) 41/428 (9.6%) 53/444 (11.9%) 53/448 (11.8%) 0.669
Hypercholesterolemia 122/460 (26.5%) 84/425 (19.8%) 100/444 (22.5%) 111/446 (24.9%) 0.096
Smoking 208/455 (45.7%) 184/426 (43.2%) 210/440 (47.7%) 194/442 (43.9%) 0.536
Killip class >1 437/462 (94.6%) 399/428 (93.2%) 422/447 (94.4%) 423/448 (94.4%) 0.815
TIMI risk score
(mean±SD, median (IQR))
2.17±1.94
2.0 (1.0–3.0)
(n=459)
2.47±2.09
2.0 (1.0–4.0)
(n=428)
2.45±2.10
2.0 (1.0–4.0)
(n=446)
2.59±2.02
2.0 (1.0–4.0)
(n=439)
0.008
Field triage 397/462 (85.9%) 317/429 (73.9%) 287/448 (64.1%) 198/449 (44.1%) <0.001
GPIIBIIIA blocker* 131/393 (33.3%) 120/385 (31.2%) 131/383 (34.2%) 118/381 (31.0%) 0.718
ST-segment deviation
(diagnostic ECG)
9.01±6.21
8.0 (5.0–11.0)
(n=297)
8.50±6.48
7.0 (4.0–11.0)
(n=279)
7.72±6.25
6.0 (4.0–10.0)
(n=311)
6.34±5.63
5.0 (3.0–9.0)
(n=303)
<0.001
Multivessel disease 247/462 (53.5%) 213/429 (49.7%) 234/447 (52.3%) 249/447 (55.7%) 0.342
*Administered in the acute phase.
BI, balloon inflation; CABG, coronary artery bypass graft; DM, diabetes mellitus; GPIIBIIIA, glycoprotein IIBIIIA; MI, myocardial infarction; min,
minutes; PCI, percutaneous coronary intervention; TIMI, thrombolysis in myocardial infarction.
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Non-anterior MI
The baseline characteristics are described in table 1.
Patients with prolonged system delay more often had a
previous CABG, were less often diagnosed in the ﬁeld
and had less ST-deviation on the diagnostic ECG. There
was a difference in previous MI and TIMI risk score
among the quartiles of system delay. The culprit vessel in
1231 patients (68.8%) was the right coronary artery and
in 425 patients (23.8%) it was the circumﬂex artery. The
time intervals are illustrated in ﬁgure 1B. All time delays
were signiﬁcantly different between the quartiles of
system delay. The median follow-up time was 5.2
(3.6–6.8) years. System delay was not associated with a
large enzymatic infarct size (table 2). After Cox regres-
sion analysis, system delay was not associated with 30-day
or with long-term mortality (ﬁgure 2B).
DISCUSSION
The present study is the ﬁrst that assesses the effect of
system delay on 30-day and on long-term mortality in
patients with anterior and non-anterior MI separately.
Interestingly, our results demonstrate that in patients with
an anterior MI, system delay was signiﬁcantly associated
with 30-day and with long-term mortality. This effect was
not apparent in patients with a non-anterior MI.
As demonstrated by Terkelsen et al,4 system delay
seems to be the reasonable time delay to focus on in
non-randomised studies, since confounding, selection
bias, information bias and recall bias hamper the other
currently discussed time delays. Another advantage of
this time delay is that this delay can be optimised during
the prehospital triage as well as during the inhospital
triage.
Highly trained paramedics from several ambulance
services transfer their patients to our high volume Isala
Hospital where over 2000 PCIs are performed yearly.
Even though all prehospital and inhospital strategies
and procedures are optimised, the variation between the
quartiles of system delay differed between 72 min (Q1)
vs ≥160 min (Q4). A possible explanation for the varia-
tions in system delay is the fact that very sick patients are
also included in this study and these patients have
longer delays. As demonstrated, in general, the TIMI
risk score increases with system delay in both patient
groups. Furthermore, D2B time increased with system
delay despite an increase in patient delay (time from SO
diagnosis). The latter might be explained by the fact
that in patients with the longest system delay (Q4), a
decrease in symptoms was more often demonstrated
after arrival in the PCI hospital. Non-system reasons
might also account for these ﬁndings. Examples of non-
system delays include delays in providing procedure
consent, difﬁcult access, difﬁculty in crossing the culprit
lesion and patients who have a cardiac arrest requiring
intubation before PCI.11
An increase in 30-day and long-term mortality was
demonstrated with system delay in patients with an
anterior MI. We anticipated that in these patients also
an increase in infarct size would be demonstrated since
a large amount of myocardium is at risk in these
patients; thus, anterior MI is a strong baseline determin-
ant of infarct size.12 Furthermore, the association
between system delay and infarct size has recently been
demonstrated by Lønborg et al13 and Tödt et al.14 In our
population, however, only an increase in infarct size was
demonstrated in patients with an anterior MI in the ﬁrst
three quartiles of system delay (Q1–Q3). An explanation
for this result might be that patients with the longest
system delays (Q4) had less severe and distinct symp-
toms, and less deviations on the ECG, which has conse-
quently lead to a prolonged D2B time. In addition,
Figure 1 Time delays. The different time intervals are shown for patients with an anterior MI (A) and patients with a non-anterior
MI (B). MI, myocardial infarction; min, minutes; PCI, percutaneous coronary intervention; SO, symptom onset.
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Lønborg et al and Tödt et al used MRI to assess the myo-
cardial area at risk; this was not used in our study.
While prolonged system delay is associated with an
increased mortality, especially in patients with an anter-
ior MI, it is of the greatest importance to minimise
system delay as much as possible. Therefore, currently
several strategies have been developed to reduce system
delay and other time delays. First, it is very important
that the patients are triaged in the ﬁeld by an ambu-
lance and are transferred straight to the catheterisation
laboratory of the PCI centre, bypassing the non-PCI
Figure 2 Mortality. Cox regression curves are shown for
long-term mortality for patients with an anterior myocardial
infarction (MI), (A) and patients with a non-anterior MI (B).
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centres and the emergency department of the PCI
centre.15 In our population, the beneﬁt of this imple-
mented strategy was obvious, that is, it was demonstrated
that the amount of patients triaged in the ﬁeld by an
ambulance in Q1 was almost twice compared with the
amount in Q4. Second, detailed identiﬁcation of the
time delays is essential so that an understanding can be
gained. Third, collaborative discussions and feedback to
staff involved in the care of patients with STEMI can
make sure that the time delays can be optimised as
much as possible. Points of discussion and feedback at
present are (1) ECG recording by the highly trained
paramedics in the ambulance, (2) central judgement of
an ECG in the hospital, (3) timely preparation of cath-
eterisation laboratory, and (4) prehospital and inhospital
logistics.16
Limitations
First, the time of diagnosis was used together with the
time of reperfusion therapy as a proxy for system delay.
Information on the time of FMC was not available for all
patients. However, a random sample of 94 cases revealed
that in 83% of these patients, the difference between
FMC (ie, EMS call) and diagnosis was ≤10 min. Second,
since the project was not randomised and dispersed over
several years, the risk of unknown confounders exists.
Third, the level of peak CK within 24 h was used as sur-
rogate parameter for infarct size.
CONCLUSIONS
Prolonged system delay signiﬁcantly increased short-term
as well as long-term mortality in patients with an anter-
ior MI. This effect was not demonstrated in patients with
a non-anterior MI. Therefore, it is of the greatest
importance to minimise system delay in patients who
present with an anterior MI.
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